[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 219,116
  • Shares Outstanding, K 2,810
  • Annual Sales, $ 19,390 K
  • Annual Income, $ -6,130 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 1.13
  • Price/Sales 10.78
  • Price/Cash Flow N/A
  • Price/Book 4.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-3.33
  • Number of Estimates 1
  • High Estimate $-3.33
  • Low Estimate $-3.33
  • Prior Year $4.17
  • Growth Rate Est. (year over year) -179.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.50 +24.77%
on 05/19/26
81.53 -4.35%
on 05/29/26
+4.21 (+5.71%)
since 05/05/26
3-Month
61.92 +25.94%
on 03/23/26
96.00 -18.77%
on 03/12/26
-1.02 (-1.29%)
since 03/05/26
52-Week
6.80 +1,046.76%
on 06/09/25
97.97 -20.40%
on 03/03/26
+70.75 (+978.56%)
since 06/05/25

Most Recent Stories

More News
This Under-the-Radar Stock Has Surged 1,300% Over the Past Year

Sol-Gel Technologies (SLGL) is a clinical-stage dermatology company focused on topical drugs for skin diseases. SLGL demonstrates exceptional technical momentum and is up 1,310% over the past 52 weeks....

SLGL : 77.98 (+4.85%)
SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know

We expect investors to focus on updates related to Sol-Gel Technologies, Ltd.’s SLGL ability to regain compliance with the recent Nasdaq requirement and other pipeline development activities when it...

MIRM : 93.48 (+1.07%)
SLGL : 77.98 (+4.85%)
PCRX : 22.75 (+0.35%)
Sol-Gel Technologies Approves Mori Arkin as Interim CEO; Provides Update on Clinical Trials and Financial Results

Mori Arkin appointed interim CEO; Sol-Gel reports ongoing clinical trials and recent financial developments.Quiver AI SummarySol-Gel Technologies, Ltd. announced that shareholders approved the appointment...

SLGL : 77.98 (+4.85%)
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Prescription volumes to date indicate strong uptake, similar to successful dermatology launches Sol-Gel receives $3.5 million milestone payment from...

SLGL : 77.98 (+4.85%)

Business Summary

Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for...

See More

Key Turning Points

3rd Resistance Point 85.69
2nd Resistance Point 82.47
1st Resistance Point 80.23
Last Price 77.98
1st Support Level 74.77
2nd Support Level 71.55
3rd Support Level 69.31

See More

52-Week High 97.97
Last Price 77.98
Fibonacci 61.8% 63.14
Fibonacci 50% 52.39
Fibonacci 38.2% 41.63
52-Week Low 6.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.